Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
复制标题
DOI:
10.1016/j.kint.2017.12.028
复制
发表时间:
2018-06
影响因子:
19.6
通讯作者:
Schiffer M
中科院分区:
文献类型:
--
作者:
Sever S;Schiffer M
Proteinuria encompasses diverse etiologies including both genetic diseases and acquired forms such as diabetic and hypertensive nephropathy. The basis of proteinuria is a disturbance in size selectivity of the glomerular filtration barrier, which largely depends on the podocyte: a terminally differentiated epithelial cell type covering the outer surface of the glomerulus. Compromised podocyte structure is one of the earliest signs of glomerular injury. The phenotype of diverse animal models and podocyte cell culture firmly established the essential role of the actin cytoskeleton in maintaining functional podocyte structure. Podocyte foot processes (FPs), actin-based membrane extensions, contain two specially and molecularly distinct “hubs” that control actin dynamics: a slit diaphragm and focal adhesions. While loss of FPs, encompasses dis-assembly of slit diaphragm multiprotein complexes, as long as cells are attached to the glomerular basement membrane, focal adhesions will be the sites in which stress due to filtration flow is counteracted by forces generated by the actin network in FPs. Numerous studies within last twenty years identified actin binding and regulatory proteins as well as integrins as essential components of signaling and actin dynamics at focal adhesions in podocytes, suggesting that some of them might become novel druggable targets for proteinuric kidney diseases. Here we review evidence supporting the idea that current treatments for chronic kidney diseases (CKD) beneficially and directly target the podocyte actin cytoskeleton associated with focal adhesions and suggest that therapeutic reagents that target the focal adhesion-regulated actin cytoskeleton in FPs have potential to modernize treatments for CKD
登录
查看更多内容
影响因子:
4.6
作者:
Ichimura K;Miyazaki N;Sadayama S;Murata K;Koike M;Nakamura K;Ohta K;Sakai T
通讯作者:
Sakai T
影响因子:
82.9
作者:
Hayek SS;Koh KH;Grams ME;Wei C;Ko YA;Li J;Samelko B;Lee H;Dande RR;Lee HW;Hahm E;Peev V;Tracy M;Tardi NJ;Gupta V;Altintas MM;Garborcauskas G;Stojanovic N;Winkler CA;Lipkowitz MS;Tin A;Inker LA;Levey AS;Zeier M;Freedman BI;Kopp JB;Skorecki K;Coresh J;Quyyumi AA;Sever S;Reiser J
通讯作者:
Reiser J
影响因子:
6.8
作者:
Bergon, Enrique;Granados, Rosario;Bergon, Marta
通讯作者:
Bergon, Marta
影响因子:
19.6
作者:
Durvasula, RV;Petermann, AT;Shankland, SJ
通讯作者:
Shankland, SJ
影响因子:
15.9
作者:
Gloy, J;Henger, A;Pavenstadt, H
通讯作者:
Pavenstadt, H